We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+33.36%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.6B
AUM Growth
+$6.01B
(+27%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
11.57%
Holding
713
New
83
Increased
216
Reduced
260
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$99.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$98.7M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$96.7M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$90.3M |
| 5 |
RTX Corp
RTX
|
+$82.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$122M |
| 2 |
Alibaba
BABA
|
+$107M |
| 3 |
Quest Diagnostics
DGX
|
+$107M |
| 4 |
Pfizer
PFE
|
+$88.9M |
| 5 |
Walt Disney
DIS
|
+$88.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Rocket Pharmaceuticals
RCKT
$351M
| $28M | 0.1% |
1,336,722
-176,632
| -12% | -$3.18M |
|
302
Bio-Techne
TECH
$11.2B
| $27.9M | 0.1% |
423,000
+2,412
| +0.6% | +$144K |
|
303
ZTO Express
ZTO
$18.1B
| $27.8M | 0.1% |
756,624
+325,321
| +75% | +$10.4M |
|
304
Intuit
INTU
$86.3B
| $27.6M | 0.1% |
93,198
-56,425
| -38% | -$15.5M |
|
305
Zebra Technologies
ZBRA
$13.7B
| $27.3M | 0.1% |
+106,472
| New | +$25M |
|
306
Linde
LIN
$235B
| $27.2M | 0.1% |
128,100
-300
| -0.2% | -$57.9K |
|
307
Saia
SAIA
$9.33B
| $27M | 0.09% |
242,980
+63,381
| +35% | +$6.07M |
|
308
Reliance Steel & Aluminium
RS
$20.5B
| $26.8M | 0.09% |
282,013
-3,196
| -1% | -$291K |
|
309
Booking.com
BKNG
$150B
| $26.7M | 0.09% |
+419,725
| New | +$25.6M |
|
|
XLRN
310
DELISTED
Acceleron Pharma
XLRN
| $26.4M | 0.09% |
277,597
+20,980
| +8% | +$2.02M |
|
311
Vroom Inc
VRM
$35.9M
| $26.4M | 0.09% |
+6,328
| New | +$24.5M |
|
312
Wayfair
W
$11.9B
| $26.4M | 0.09% |
+133,424
| New | +$20M |
|
313
Marcus & Millichap
MMI
$1.18B
| $26.1M | 0.09% |
903,428
+27,601
| +3% | +$778K |
|
314
TG Therapeutics
TGTX
$8.19B
| $25.8M | 0.09% |
1,326,685
+380,921
| +40% | +$6.13M |
|
315
SolarEdge
SEDG
$2.54B
| $25.5M | 0.09% |
184,001
-163,867
| -47% | -$20M |
|
316
SLB Ltd
SLB
$72.6B
| $25.5M | 0.09% |
1,385,700
-24,700
| -2% | -$433K |
|
317
Sprout Social
SPT
$509M
| $24.8M | 0.09% |
917,134
+386,624
| +73% | +$8.48M |
|
318
EverQuote
EVER
$886M
| $24.4M | 0.09% |
418,970
+17,579
| +4% | +$826K |
|
|
BPMC
319
DELISTED
Blueprint Medicines
BPMC
| $24.2M | 0.08% |
310,659
+13,490
| +5% | +$912K |
|
|
WRI
320
DELISTED
Weingarten Realty Investors
WRI
| $24.1M | 0.08% |
1,275,243
+172,717
| +16% | +$3.02M |
|
|
SPLK
321
DELISTED
Splunk Inc
SPLK
| $23.8M | 0.08% |
119,903
+18,640
| +18% | +$2.95M |
|
322
Starwood Property Trust
STWD
$6.02B
| $23.7M | 0.08% |
1,587,200
+414,200
| +35% | +$5.58M |
|
323
Guardant Health
GH
$20.2B
| $23.4M | 0.08% |
288,616
-57,903
| -17% | -$4.67M |
|
324
Carlisle Companies
CSL
$15B
| $23M | 0.08% |
192,165
-147,791
| -43% | -$17.8M |
|
|
DCPH
325
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $23M | 0.08% |
384,805
-9,215
| -2% | -$493K |
|
Similar funds
Lord, Abbett & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Lord, Abbett & Co held 713 positions worth $28.6B, up 27% from $22.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Lord, Abbett & Co withdrew a net $1.19B in Q2 2020, closing 78 positions and reducing 260 holdings. Its most notable exit was Raytheon Company, an estimated $87.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Lord, Abbett & Co opened a new position in Immunomedics Inc worth $117M.
- Lord, Abbett & Co's largest Q2 2020 buy was Immunomedics Inc: 3,306,343 shares worth $117M.
- Lord, Abbett & Co added most to Texas Instruments in Q2 2020, an estimated $99.4M increase.
- Lord, Abbett & Co's biggest Q2 2020 reduction was Shopify, cutting an estimated $122M.
- Lord, Abbett & Co fully exited Raytheon Company in Q2 2020, selling an estimated $87.9M.
- Lord, Abbett & Co's ten largest holdings make up 12% of its $28.6B portfolio in Q2 2020.
- Lord, Abbett & Co opened 83 new positions and closed 78 in Q2 2020.
- Lord, Abbett & Co's portfolio value rose 27% quarter-over-quarter to $28.6B.
Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.